SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of 196.29 million. The enterprise value is 227.78 million.
Market Cap | 196.29M |
Enterprise Value | 227.78M |
Important Dates
The next estimated earnings date is Wednesday, March 26, 2025.
Earnings Date | Mar 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.53 million shares outstanding. The number of shares has increased by 77.92% in one year.
Current Share Class | n/a |
Shares Outstanding | 8.53M |
Shares Change (YoY) | +77.92% |
Shares Change (QoQ) | -13.93% |
Owned by Insiders (%) | 3.69% |
Owned by Institutions (%) | 2.97% |
Float | 6.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.44 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 570.60 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.32, with an EV/FCF ratio of 662.16.
EV / Earnings | -585.56 |
EV / Sales | 7.77 |
EV / EBITDA | 46.32 |
EV / EBIT | 57.90 |
EV / FCF | 662.16 |
Financial Position
The company has a current ratio of 0.12
Current Ratio | 0.12 |
Quick Ratio | 0.07 |
Debt / Equity | n/a |
Debt / EBITDA | 7.07 |
Debt / FCF | 101.03 |
Interest Coverage | 0.28 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 11.66% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | 945,226 |
Profits Per Employee | -12,548 |
Employee Count | 31 |
Asset Turnover | 1.39 |
Inventory Turnover | 3.09 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +370.77% in the last 52 weeks. The beta is 1.16, so SANUWAVE Health's price volatility has been higher than the market average.
Beta (5Y) | 1.16 |
52-Week Price Change | +370.77% |
50-Day Moving Average | 20.35 |
200-Day Moving Average | 10.72 |
Relative Strength Index (RSI) | 53.93 |
Average Volume (20 Days) | 9,143 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.89 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of 29.30 million and -389,000 in losses. Loss per share was -0.13.
Revenue | 29.30M |
Gross Profit | 21.34M |
Operating Income | 3.93M |
Pretax Income | -385,000 |
Net Income | -389,000 |
EBITDA | 4.92M |
EBIT | 3.93M |
Loss Per Share | -0.13 |
Balance Sheet
The company has 3.26 million in cash and 34.76 million in debt, giving a net cash position of -31.50 million or -3.69 per share.
Cash & Cash Equivalents | 3.26M |
Total Debt | 34.76M |
Net Cash | -31.50M |
Net Cash Per Share | -3.69 |
Equity (Book Value) | -60.26M |
Book Value Per Share | -19.13 |
Working Capital | -71.61M |
Cash Flow
In the last 12 months, operating cash flow was 429,000 and capital expenditures -85,000, giving a free cash flow of 344,000.
Operating Cash Flow | 429,000 |
Capital Expenditures | -85,000 |
Free Cash Flow | 344,000 |
FCF Per Share | 0.04 |
Margins
Gross margin is 72.84%, with operating and profit margins of 13.43% and -1.33%.
Gross Margin | 72.84% |
Operating Margin | 13.43% |
Pretax Margin | -1.31% |
Profit Margin | -1.33% |
EBITDA Margin | 16.78% |
EBIT Margin | 13.43% |
FCF Margin | 1.17% |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -77.92% |
Shareholder Yield | -77.92% |
Earnings Yield | -0.54% |
FCF Yield | 0.18% |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 0.0026667.
Last Split Date | Oct 18, 2024 |
Split Type | Reverse |
Split Ratio | 0.0026667 |
Scores
SANUWAVE Health has an Altman Z-Score of -17.14. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -17.14 |
Piotroski F-Score | n/a |